Full-Spectrum Turnkey Solution for mRNA Vaccine Commercial & Clinical Manufacturing
Our turnkey mRNA vaccine manufacturing facility design delivers a fully integrated, end-to-end building and process solution tailored exclusively for mRNA bioproduction, covering site planning, architectural design, process layout, utility integration, cleanroom construction, and validation handover. Differentiated from general biopharmaceutical factories, our design fully adapts to the unique production characteristics of mRNA technology, including strict RNase-free control, ultra-clean microbial environments, and segmented production workflows for plasmid amplification, in vitro transcription, and LNP formulation. We eliminate disjointed engineering links and coordination costs between multiple contractors, providing a one-stop deliverable from blueprint design to fully functional, inspection-ready manufacturing facilities for clinical trial and commercial mass production.
FDA cGMP & Global Regulatory Compliant mRNA-Specific Layout Design
All facility design schemes strictly comply with FDA cGMP, ICH Q7, and international vaccine manufacturing regulatory standards, focusing on the core risk control points of mRNA vaccine production. We implement scientific functional zoning and strict unidirectional material and personnel flow to effectively prevent RNase contamination, cross-contamination between process segments, and foreign microbial intrusion. The design independently sets up plasmid production zones, mRNA synthesis zones, LNP encapsulation zones, sterile filling zones, and cold-chain storage zones, with fully isolated air systems and material transfer channels. Every layout detail, environmental parameter, and facility specification is embedded with regulatory compliance logic, ensuring full traceability of production conditions and smooth approval of global regulatory audits.
RNase-Free & Aseptic High-Grade Cleanroom System Engineering
Targeting the extreme sensitivity of mRNA molecules to RNase, microbial pollution, and environmental fluctuations, we customize high-standard ISO 5/7 classified cleanroom systems exclusive for mRNA vaccine manufacturing. The whole factory adopts RNase-free anti-pollution design, featuring seamless, non-shedding, corrosion-resistant special wall and floor materials, no sanitary dead corners, and dedicated cleaning and disinfection systems to completely eliminate RNase residues. The precision HVAC system achieves real-time control of differential pressure, air change rate, temperature and humidity, while independent high-efficiency filtration and fresh air purification systems maintain ultra-sterile production environments. Combined with professional low-temperature production and cold-storage supporting facilities, the design fully guarantees the stability and biological activity of mRNA intermediates and finished vaccines.
Process-Integrated Design with Fast Launch & Scalable Production Capacity
We deeply integrate mRNA core production processes with facility engineering, realizing perfect matching between factory space and key production equipment including fermentation systems, purification systems, ultrafiltration concentration systems, and LNP mixing and filling systems. The turnkey design reserves flexible expansion interfaces for production lines and utilities, supporting seamless capacity upgrading from small-batch clinical production to large-scale commercial manufacturing. Meanwhile, we deliver complete DQ/IQ/OQ/PQ validation documents, standard operating procedure systems, and post-construction technical guidance. The overall solution shortens project construction and commissioning cycles, helping clients quickly complete facility qualification, realize GMP-compliant production, and accelerate mRNA vaccine product launch and market layout.
